About Protein NOXP20
Protein NOXP20 (FAM114A1) is a protein
from Homo sapiens identified by UniProt accession
Q8IWE2, 563 residues long.
MolForge cross-references it against 0 known binders and
88 disease associations.
Target properties
| Protein name | Protein NOXP20 |
| UniProt accession | Q8IWE2 |
| Gene | FAM114A1 |
| Organism | Homo sapiens |
| Length | 563 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (88)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.34
- mean corpuscular volume · score 0.33
- bilirubin measurement · score 0.32
- body height · score 0.30
- mean corpuscular hemoglobin · score 0.30
- mean corpuscular hemoglobin concentration · score 0.29
- mean reticulocyte volume · score 0.27
- red blood cell density measurement · score 0.26
- lymphocyte count · score 0.22
- asthma · score 0.13
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IWE2-F1 | alphafold | PREDICTED | 63.59 | — |
Amino-acid sequence (563 residues)
MSDDAGDTLA TGDKAEVTEM PNSDSLPEDA EVHCDSAAVS HEPTPADPRG EGHENAAVQG AGAAAIGPPV QPQDANALEP PLNGDVTEDT LAECIDSVSL EAEPRSEIPL QEQNYLAVDS PPSGGGWAGW GSWGKSLLSS ASATVGHGLT AVKEKAGATL RIHGVNSGSS EGAQPNTENG VPEITDAATD QGPAESPPTS PSSASRGMLS AITNVVQNTG KSVLTGGLDA LEFIGKKTMN VLAESDPGFK RTKTLMERTV SLSQMLREAK EKEKQRLAQQ LTMERTAHYG MLFDEYQGLS HLEALEILSN ESESKVQSFL ASLDGEKLEL LKNDLISIKD IFAAKELENE ENQEEQGLEE KGEEFARMLT ELLFELHVAA TPDKLNKAMK RAHDWVEEDQ TVVSVDVAKV SEEETKKEEK EEKSQDPQED KKEEKKTKTI EEVYMSSIES LAEVTARCIE QLHKVAELIL HGQEEEKPAQ DQAKVLIKLT TAMCNEVASL SKKFTNSLTT VGSNKKAEVL NPMISSVLLE GCNSTTYIQD AFQLLLPVLQ VSHIQTSCLK AQP
Explore Protein NOXP20 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets